Vivani Medical, Inc. is classed by the SEC under Electromedical & Electrotherapeutic Apparatus (industry code 3845), based in Alameda, CA. Its latest filed balance sheet (2025-12-31) shows total assets of $42 million (its filed statements).
Product businessElectromedical & Electrotherapeutic ApparatusAlameda, CAfilings since 20034 of 9 filed, 5 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3845, Electromedical & Electrotherapeutic Apparatus); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.8 out of ten, 4 of 9 metrics filed and 5 estimated: past 2.7 out of ten, present 4.5 out of ten, future 7.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 3.3 out of ten. 11 warning events since 2017; the latest 2023-12-27. 33rd percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 1.3 out of ten. 6 filed years; profitable in 0 of 10. 13th percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 4.6 out of ten. CrossAssetData estimate 4.6/10, confidence 35 of 100 (one part). 46th percentile among 27 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Financial health (present): 3.2 out of ten. ROE -169%: lost 169¢ per shareholder dollar. Leverage 60%: owes 60¢ per asset dollar. 32nd percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 5.5 out of ten. CrossAssetData estimate 5.5/10, confidence 20 of 100 (family median). 50th percentile among 24 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
Leadership (present): 5.8 out of ten. CrossAssetData estimate 5.8/10, confidence 35 of 100 (one part). 58th percentile among 25 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Room to expand (future): 8.7 out of ten. CrossAssetData estimate 8.7/10, confidence 35 of 100 (one part). 87th percentile among 27 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Growth drivers (future): 6.8 out of ten. top 32% of 25 in its family for growth drivers. 68th percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 4.3 out of ten. CrossAssetData estimate 4.3/10, confidence 35 of 100 (one part). 43rd percentile among 23 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
The filing record
Newest annual report: Form 10-K filed 2026-03-26 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-13 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-13 (on EDGAR). Newest filing: Form 424B5, 2026-09-25. Filings on record since 2003. Read from EDGAR 2026-10-12.
Who runs it
Mendelsohn, Adam (Chief Executive Officer); Baldor, Anthony (Chief Financial Officer); Dwyer, Donald (Chief Business Officer); Le, Truc (Chief Operations Officer); Porter, Lisa Ellen (Chief Medical Officer); Bradbury, Daniel (director); Williams, Gregg (director); Moretti, August J (director); Larson, Alexandra L.p. (director); Mendelsohn, Aaron (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.